XML 45 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8, Stock Based Compensation (Tables)
9 Months Ended
Jun. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]
Performance Share Awards

A summary of the activity of nonvested performance-based share unit awards for the nine months ended June 30, 2017:
 
 
Weighted
Average
Price
 
Shares/Units
Subject to
PSU
Nonvested, September 30, 2016
 
$

 

Converted and nonvested on October 31, 2016
 

 

Granted
 
44.60

 
236,034

Vested
 

 

Forfeited
 

 

Nonvested, June 30, 2017
 
$
44.60

 
236,034

Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity [Table Text Block]
Stock Appreciation Rights

A summary of SAR activity for the nine months ended June 30, 2017:
 
 
Weighted
Average
SAR Price
 
Shares
Subject to
SAR
 
Weighted
Average
Remaining
Contractual
Life (years)
 
Aggregate
Intrinsic
Value
(in  millions)
Outstanding, September 30, 2016
 
$
31.26

 
654,694

 
 
 
 
Exercised
 
29.68

 
(9,470
)
 
 
 
 
Converted
 
33.16

 
41,713

 
 
 
 
Converted and outstanding on October 31, 2016
 
31.40

 
686,937

 
 
 
 
Granted
 

 

 
 
 
 
Exercised
 
31.20

 
(50,266
)
 
 
 
 
Forfeited or expired
 
48.32

 
(4,757
)
 
 
 
 
Outstanding, June 30, 2017
 
$
31.29

 
631,914

 
3.7
 
$
11

Exercisable, June 30, 2017
 
$
27.95

 
594,610

 
3.5
 
$
10

 
 
 
 
 
 
 
 
 
JCI outstanding, June 30, 2017
 
$
31.22

 
571,699

 
3.7
 
$
9

Adient outstanding, June 30, 2017
 
32.01

 
60,215

 
3.8
 
2

Total outstanding, June 30, 2017
 
$
31.29

 
631,914

 
3.7
 
$
11

 
 
 
 
 
 
 
 
 
JCI exercisable, June 30, 2017
 
$
27.61

 
537,786

 
3.5
 
$
8

Adient exercisable, June 30, 2017
 
31.11

 
56,824

 
3.5
 
2

Total exercisable, June 30, 2017
 
$
27.95

 
594,610

 
3.5
 
$
10

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]
Restricted Stock

A summary of the activity of nonvested restricted stock awards for the nine months ended June 30, 2017:
 
 
Weighted
Average
Price
 
Shares/Units
Subject to
Restriction
Nonvested, September 30, 2016
 
$
46.42

 
1,320,448

Converted
 
48.06

 
135,026

Converted and nonvested on October 31, 2016
 
46.57

 
1,455,474

Granted
 
45.19

 
1,162,213

Vested
 
50.30

 
(281,084
)
Forfeited
 
44.65

 
(47,297
)
Nonvested, June 30, 2017
 
$
45.46

 
2,289,306

 
 
 
 
 
JCI nonvested, June 30, 2017
 
$
45.57

 
1,031,972

Adient nonvested, June 30, 2017
 
45.41

 
1,257,334

Total nonvested, June 30, 2017
 
$
45.46

 
2,289,306


At June 30, 2017, Adient had approximately $63 million of total unrecognized compensation cost related to nonvested restricted stock arrangements granted. That cost is expected to be recognized over a weighted-average period of 2.1 years.

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
Stock Options

A summary of stock option activity for the nine months ended June 30, 2017:
 
 
Weighted
Average
Option Price
 
Shares
Subject to
Option
 
Weighted
Average
Remaining
Contractual
Life (years)
 
Aggregate
Intrinsic
Value
(in millions)
Outstanding, September 30, 2016
 
$
32.42

 
2,336,028

 
 
 
 
Exercised
 
27.22

 
(6,280
)
 
 
 
 
Forfeited or expired
 
31.71

 
(3,330
)
 
 
 
 
Converted
 
33.28

 
169,125

 
 
 
 
Converted and outstanding on October 31, 2016
 
32.49

 
2,495,543

 
 
 
 
Granted
 

 

 
 
 
 
Exercised
 
27.13

 
(922,734
)
 
 
 
 
Forfeited or expired
 
26.10

 
(3,083
)
 
 
 
 
Outstanding, June 30, 2017
 
$
35.65

 
1,569,726

 
4.8
 
$
23

Exercisable, June 30, 2017
 
$
29.67

 
1,298,785

 
4.1
 
$
22

 
 
 
 
 
 
 
 
 
JCI outstanding, June 30, 2017
 
$
35.97

 
1,354,043

 
4.9
 
$
16

Adient outstanding, June 30, 2017
 
33.67

 
215,683

 
4.1
 
7

Total outstanding, June 30, 2017
 
$
35.65

 
1,569,726

 
4.8
 
$
23

 
 
 
 
 
 
 
 
 
JCI exercisable, June 30, 2017
 
$
29.28

 
1,107,731

 
4.2
 
$
16

Adient exercisable, June 30, 2017
 
31.90

 
191,054

 
3.6
 
6

Total exercisable, June 30, 2017
 
$
29.67

 
1,298,785

 
4.1
 
$
22


At June 30, 2017, Adient had approximately $0.3 million of total unrecognized compensation cost related to nonvested stock options granted. That cost is expected to be recognized over a weighted-average period of 1.1 years.